|
J Biol Chem, Vol. 275, Issue 4, 2938-2942, January 28, 2000
Distinct Protein Domains Are Responsible for the Interaction of
Hrs-2 with SNAP-25
THE ROLE OF Hrs-2 IN 7 S COMPLEX FORMATION*
Susan
Tsujimoto and
Andrew J.
Bean
From the Department of Neurobiology and Anatomy and the W. M. Keck Center for the Neurobiology of Learning and Memory, University of
Texas Medical School, Houston, Texas 77030
 |
ABSTRACT |
Regulated secretion of neurotransmitter at the
synapse is likely to be mediated by dynamic protein interactions
involving components of the vesicle (vesicle-associated membrane
protein; VAMP) and plasma membrane (syntaxin and synaptosomal
associated protein of 25 kDa (SNAP-25)) along with additional molecules
that allow for the regulation of this process. Recombinant Hrs-2
interacts with SNAP-25 in a calcium-dependent manner (they
dissociate at elevated calcium levels) and inhibits neurotransmitter
release. Thus, Hrs-2 has been hypothesized to serve a negative
regulatory role in secretion through its interaction with SNAP-25. In
this report, we show that Hrs-2 and SNAP-25 interact directly through specific coiled-coil domains in each protein. The presence of syntaxin
enhances the binding of Hrs-2 to SNAP-25. Moreover, while both Hrs-2
and VAMP can separately bind to SNAP-25, they cannot bind
simultaneously. Additionally, the presence of Hrs-2 reduces the
incorporation of VAMP into the syntaxin·SNAP-25·VAMP (7 S) complex. These findings suggest that Hrs-2 may modulate exocytosis by
regulating the assembly of a protein complex implicated in membrane fusion.
 |
INTRODUCTION |
Regulated release of neurotransmitter at the synapse is necessary
for efficient communication between neurons. Calcium transients, produced by membrane depolarization and the subsequent opening of
voltage-gated calcium channels, provide the trigger for fusion of the
vesicle and plasma membrane lipid bilayers allowing the release of
neurotransmitter into the synaptic cleft (1). Biochemical and genetic
analyses have identified integral protein components of the vesicle and
the plasma membrane along with additional regulatory factors that are
hypothesized to be involved in the exocytotic process (2-5).
Synaptosomal associated protein of 25 kDa
(SNAP-25)1 is a component of
the core protein complex believed to be central to the exocytotic
process (7, 8). SNAP-25 is localized to the plasma membrane, via
palmitylation, where it interacts with syntaxin, an integral membrane
protein found primarily on the plasma membrane (9-11). Upon binding,
syntaxin induces structural changes in SNAP-25 that promote the binding
of vesicle-associated membrane protein (VAMP) and the subsequent
formation of an SDS-resistant ternary complex that sediments at 7 S
(11-14). The ternary complex, recently crystallized, has a structural
arrangement consisting of four entwined coiled-coils (15, 16). SNAP-25
contributes two coiled-coils to the complex, while syntaxin and VAMP
contribute one coiled-coil each. Although otherwise quite stable when
packed together as a four-helix bundle, complex integrity is
compromised when SNAP-25 is cleaved with either botulinum neurotoxin
type A or E prior to complex formation (17, 18). Such cleavage
effectively abolishes neurotransmitter release (13) and suggests that
the integrity of the four helical bundle is essential for exocytosis.
We previously identified a novel protein, Hrs-2, that interacts with
SNAP-25 (19). The interaction of Hrs-2 with SNAP-25 is inhibited by
calcium at concentrations ( 100 µM) thought to be
essential for neurotransmitter release. Moreover, recombinant Hrs-2
inhibits 3H-labeled norepinephrine release from
permeabilized PC12 cells (19). Thus, Hrs-2 interacts with a known
component of the vesicular trafficking machinery in a calcium-sensitive
manner and inhibits calcium-triggered exocytosis, suggesting a role for
Hrs-2 in the exocytic machinery.
The 7 S complex (SNAP-25, syntaxin, and VAMP) has been argued to
constitute the minimal machinery necessary for membrane fusion (20,
21). However, the molecular mechanisms that regulate complex assembly
remain unresolved. Because SNAP-25 is a core constituent of the 7 S
complex, we explored the role that Hrs-2 may play in 7 S complex
assembly. We identified the sites of interaction between Hrs-2 and
SNAP-25 and examined the effects of Hrs-2 on the ability of SNAP-25 to
associate with syntaxin or VAMP and the effect of Hrs-2 on 7 S complex assembly.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction enzymes and DNA modifying enzymes
were from Promega and Stratagene. Media reagents were from Difco.
Materials for SDS-polyacrylamide gel electrophoresis were from Bio-Rad. Horseradish peroxidase-conjugated and 125I-labeled
anti-rabbit and anti-mouse antisera were obtained from Amersham
Pharmacia Biotech. Bovine serum albumin, glutathione-agarose, and
Ponceau S were purchased from Sigma. The pGEX-4T1 and pGEX-KG vectors
(Amersham Pharmacia Biotech) were used to express recombinant proteins
fused to glutathione S-transferase (GST) in the NM522 strain
of Escherichia coli. The Hta vector (Life Technologies, Inc.) was used to express recombinant Hrs-2 fused to a His6
tag via infection of SF21 insect cells.
Plasmid Construction--
Construction of plasmids encoding GST
fusion proteins of full-length mouse SNAP-25 (amino acids 1-206),
full-length rat syntaxin 1A11 (amino acids 1-288), and full-length rat
VAMP2 (amino acids 1-116) were previously described (sn25 in Ref. 19,
sytx in Refs. 22 and 23, and VAMP in Ref. 14). A plasmid encoding an
carboxyl-terminal truncation of the rat GST-Hrs-2 fusion protein (amino
acids 1-478) was prepared by digesting the full-length clone with
NheI and BamHI followed by Klenow treatment
(30 °C incubation for 10 min) and religation. Two plasmids encoding
short and long carboxyl-terminal truncations of the GST-SNAP-25 fusion
protein were prepared. The shorter construct, GST-SNAP-25 (amino acids
1-31) was generated by partial restriction digest of the full-length
clone with PstI followed by religation. The longer
construct, GST-SNAP-25 (amino acids 1-95), was prepared as described
(16). Plasmids encoding internal segments of GST-Hrs-2 (coiled-coils 1 and 2 (amino acids 449-562) and coiled-coil 2 (amino acids 478-562))
and the carboxyl-terminal end of GST-SNAP-25 (amino acids 150-206)
were prepared by insertion of the appropriate polymerase chain
reaction-amplified fragment into pGEX-4T1 (primer sequences available
upon request). Constructs generated by restriction digest were
sequenced (Sequenase 2.2; U.S. Biochemical Corp.) at the 5'- and
3'-ends to check for proper insertion. All polymerase chain
reaction-generated constructs were sequenced in their entirety to
ascertain fidelity of sequence.
Expression and Purification of Fusion Proteins--
The
His6-tagged Hrs-2 fusion protein, and all GST fusion
proteins were prepared as described (24), with the exception that the
recombinant Hrs-2 fusion protein was eluted in batch format using 500 mM imidazole in PBST (phosphate-buffered saline and 0.05%
Tween 20). Under these conditions, Hrs-2 is 100%
monomeric.2 Recombinant
SNAP-25, syntaxin 1A11, and VAMP were cleaved from the GST moiety using
thrombin (7.5 units/ml; Amersham Pharmacia Biotech) in a buffer
containing 50 mM Tris, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2, 0.1% -mercaptoethanol. The
cleavage reaction was stopped following end-over-end incubation at room
temperature for 1 h (syntaxin 1A11), 2 h (VAMP2), or 8 h
(SNAP-25) with phenylmethylsulfonyl fluoride (0.1 mM). In
some cases, solublized proteins were concentrated using Centricon
concentrators (Millipore Corp.). All soluble proteins were precleared
with glutathione-agarose prior to quantitation and binding. Protein
concentrations were estimated by Coomassie Blue staining of protein
bands following SDS-polyacrylamide electrophoresis using bovine serum
albumin as a standard.
Western Blotting--
Proteins were resolved on
SDS-polyacrylamide gels (12-17% acrylamide) and transferred to
nitrocellulose. Blots were stained with Ponceau S in order to ensure
accuracy of protein loading, blocked in blotto (5% dry milk in PBST),
and incubated with primary antibody diluted in blotto. The following
antibodies were used for detection of transferred proteins: 48-5 (Hrs-2
mouse monoclonal antibody, 1:1000 (24), anti-SNAP-25 (mouse monoclonal
antibody, 1:1000; obtained from Sternberger Antibodies), HPC-1
(syntaxin mouse monoclonal antibody, 1:1000 (23), and anti-VAMP (rabbit polyclonal, 1:1000, obtained from StressGen Biotechnologies). Filters
were washed, and horseradish peroxidase- or 125I-conjugated
secondary antibody was applied. Antibodies were visualized using either
enhanced chemiluminescence (Pierce) or PhosphorImager analysis
(Molecular Dynamics).
In Vitro Binding Assays--
For domain mapping experiments, 2 µg of SNAP-25 (Fig. 1) or Hrs-2 (Figs.
2 and 3)
and 0.5 µg of various GST fusion proteins immobilized on
glutathione-agarose were incubated in binding buffer (20 mM
HEPES, pH 7.4, 150 mM KCl, and 0.05% Tween 20) to a final reaction volume of 35 µl. Following an end-over-end incubation at
4 °C for 1 h, samples were washed three times with 150 µl of binding buffer, solublized in SDS sample buffer, resolved by
SDS-polyacrylamide gel electrophoresis, and subjected to immunoblot
analysis using enhanced chemiluminescence.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Identification of the domain of Hrs-2
necessary for binding to SNAP-25. Three GST-Hrs-2 fusion proteins
encompassing residues 1-478, 449-562, and 478-563 (depicted in the
schematic diagram, top) were generated
by bacterial expression, immobilized on glutathione-agarose beads, and
assayed for binding interactions with full-length SNAP-25. SNAP-25
binds to Hrs-2 truncation mutants that contain the second of two
coiled-coil regions (lanes 3 and 4).
Neither GST control beads (lane 1) nor the Hrs-2
truncation mutant containing a FYVE-type zinc finger and the first of
the two coiled-coil regions (lane 2) were able to
bind SNAP-25. These data suggest that the second coiled-coil of Hrs-2
is necessary and sufficient to bind to SNAP-25.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Identification of the domain of SNAP-25
necessary for binding to Hrs-2. Three GST-SNAP-25
fusion proteins, encompassing residues 1-95, 1-31, and 150-206, in
addition to full-length GST-SNAP-25 (depicted in the
schematic diagram, top) were generated
by bacterial expression, immobilized on glutathione-agarose beads, and
assayed for binding interactions with full-length Hrs-2. Hrs-2 binds to
both full-length SNAP-25 and a SNAP-25 truncation mutant that contains
the first two coiled-coil regions (lanes 2 and
3). Neither GST control beads (lane 1)
nor the SNAP-25 truncation mutants containing the first or the third
coiled-coil regions (lanes 4 and 5)
were able to bind Hrs-2. Thus, the second coiled-coil of SNAP-25
(residues 32-95) is required for Hrs-2 binding.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Binding interaction of Hrs-2 with members of
the 7 S core complex. Glutathione S-transferase fusion
proteins containing glutathione S-transferase (control,
lane 1), full-length SNAP-25 (lane
2), VAMP2 (lane 3), and syntaxin 1A11
(lane 4) were prepared as described under
"Experimental Procedures" and immobilized on glutathione-agarose
beads. Hrs-2 physically interacts with SNAP-25 but not with either
syntaxin 1A11 or VAMP2.
|
|
To understand the effects of Hrs-2 on complex formation (Figs.
4 and 5),
Hrs-2 (0-10 µM) or syntaxin 1A11 (0-3.2
µM) and 0.2 µM GST-SNAP-25 immobilized on
glutathione-agarose were mixed in binding buffer and incubated as
described above. VAMP2 was added to the GST-SNAP-25/Hrs-2 reactions in
a final concentration of 4 µM, and 2 µM
Hrs-2 was added to the GST-SNAP-25/syntaxin 1A11 reactions. As a
control, a second set of GST-SNAP-25/syntaxin 1A11 reactions to which
no Hrs-2 was added was processed simultaneously. The reactions were
incubated end-over-end, at 4° C for an additional 1 h and then
processed as described above with the exception that 125I-conjugated secondary antibody and PhosphorImager
analysis were used to analyze the immunoblots. GST-SNAP-25
(bottom panels of Figs. 4 and 5) was stained with
Ponceau S to determine the accuracy of loading. Quantitation of
antibody-detected protein binding is reported in optical density
units.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 4.
Syntaxin 1A11 potentiates Hrs-2 binding to
SNAP-25. A, quantitation of syntaxin 1A11 ( ) bound
to SNAP-25 in the presence (left) and absence
(right) of Hrs-2 ( ) (expressed as optical density)
versus concentration of syntaxin added in the reaction.
B, a constant amount of immobilized GST-SNAP-25 (0.2 µM,
lower panels) was incubated with varying amounts of syntaxin 1A11
(0-3.2 µM, middle panels) in the presence
(upper left panel) or absence
(upper right panel) of a constant
amount of Hrs-2 (2 µM). Samples were processed, and immunoblots were
visualized as described under "Experimental Procedures." For Hrs-2
binding in the presence of GST-SNAP-25/syntaxin 1A11, the pixel values
(× 1000) for the five concentrations of syntaxin 1A11 were 0, 0.8, 1.6, 4.1, and 5.2 (left panel) and 1.0, 0.2, 0.8, 3.5, and 3.4 (right panel). The corresponding
pixel values (× 1000) for Hrs-2 were 50.2, 94.0, 111.9, 106.7, and 107.3 (left panel) and 0, 0, 0, 0, and 0 (right panel).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Hrs-2 interferes with VAMP2 binding to
SNAP-25. A, the quantitation of VAMP2 ( ) and Hrs-2
( ) bound to SNAP-25 (expressed in optical density units)
versus concentration of syntaxin in the reaction.
B, a constant amount of immobilized GST-SNAP-25 (0.2 µM,
lower panel) was incubated with varying amounts
of Hrs-2 (0-10 µM, middle panel) and a
constant amount of VAMP2 (4 µM, upper panel).
Samples were processed, and immunoblots were visualized as described
under "Experimental Procedures." For VAMP binding in the presence
of GST-SNAP-25·Hrs-2 (Fig. 5), the pixel values (× 1000) for the six
concentrations of Hrs-2 were 0, 1.4, 7.4, 82.9, 108.6, and 102.3. The
corresponding pixel values (× 1000) for VAMP were 5.8, 4.9, 5.0, 0.7, 2.0, and 0.9.
|
|
To examine the effect of Hrs-2 on the efficiency of 7 S complex
formation (Fig. 6), GST-syntaxin (1.5 µM, glutathione-agarose-immobilized), SNAP-25 (1.5 µM, soluble), and excess VAMP (5.5 µM,
soluble) were incubated in the presence of increasing amounts of
soluble Hrs-2 (0, 1.5, 3.0, 4.5, and 6.0 µM). The
reactants were mixed together in binding buffer (25-µl final reaction
volume), incubated end-over-end at 4 °C for 1.5 h, and then
processed for quantitation by PhosphorImager analysis as described
above. Initial attempts at forming the 7 S complex on
glutathione-immobilized SNAP-25 were unsuccessful; therefore,
glutathione-immobilized syntaxin was used in all subsequent reactions
requiring 7 S complex formation. Ponceau S stain of the GST-syntaxin
(bottom panel) was used to determine accuracy of
protein loading. Quantitation of antibody-detected protein binding is
reported in optical density units.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Hrs-2 decreases the efficiency of 7 S complex
formation. Quantitation of the amount of Hrs-2 (A) or
VAMP (B) incorporated into the 7 S complex (expressed in
optical density units) in the presence of increasing amounts (0, 1.5, 3.0, 4.5, and 6.0 µM) of Hrs-2 is shown. C,
glutathione-immobilized GST-syntaxin, SNAP-25, and VAMP were incubated
in the presence of increasing amounts of Hrs-2. Samples were processed,
and immunoblots were visualized as described under "Experimental
Procedures." For the five concentrations of Hrs-2, the pixel values
(×1000) for VAMP incorporated into the 7 S complex were 5.5, 2.3, 3.3, 2.2, and 1.4. The corresponding pixel values (× 1000) for Hrs-2 bound
were 0, 25.6, 58.1, 55.4, and 56.8.
|
|
 |
RESULTS |
To determine the domain of Hrs-2 that binds to SNAP-25, we
constructed a set of GST fusion proteins containing regions of Hrs-2
predicted to form structural motifs (Fig. 1, top). These truncation mutants were expressed, bound to glutathione-agarose beads,
and then examined for interaction with full-length soluble SNAP-25
during an in vitro binding assay. As shown in Fig. 1
(bottom), SNAP-25 bound to Hrs-2 truncations that contained
the second of two coiled-coil regions and not to GST beads alone or to
an Hrs-2 truncation mutant missing the second coiled-coil region. Since SNAP-25 was able to bind to the Hrs-2 truncation containing only the
second coiled-coil, we conclude that the second coiled-coil of Hrs-2 is
both necessary and sufficient for binding to SNAP-25.
In a similar manner, we determined the domain of SNAP-25 that binds to
Hrs-2. GST fusion proteins containing coiled-coil regions of SNAP-25
were constructed, expressed, immobilized on glutathione-agarose, and
then assayed for interaction with full-length soluble Hrs-2. Both
full-length SNAP-25 and an amino-terminal truncation construct containing the first two coiled-coils were able to bind Hrs-2. Neither
a construct containing the first nor one containing the third
coiled-coil was able to interact with Hrs-2. Thus, we conclude that the
SNAP-25 binding domain necessary for interaction with Hrs-2 contains
residues 32-95, the region encompassing the second coiled-coil motif.
Since SNAP-25 has been previously shown to interact with both syntaxin
1A and VAMP, we examined whether Hrs-2, when in complex with SNAP-25,
might affect the ability of SNAP-25 to interact with either syntaxin or
VAMP. Hrs-2 did not physically interact with either syntaxin or VAMP
(Fig. 3). Therefore, any effect Hrs-2 might have on the ability of
SNAP-25 to interact with syntaxin 1A or VAMP would be consequent to the
interaction of Hrs-2 with SNAP-25.
We first examined the ability of syntaxin 1A to associate with
GST-SNAP-25 when Hrs-2 was present. As a control, we examined the
association of GST-SNAP-25 with Hrs-2 in the absence of syntaxin 1A. At
all concentrations, Hrs-2 did not affect the amount of syntaxin able to
bind to SNAP-25 (Fig. 4). However, we observed that the amount of Hrs-2
bound to SNAP-25 in the presence of syntaxin was greater than the
amount bound in its absence, suggesting that syntaxin facilitates the
binding of Hrs-2 to SNAP-25 (data not shown). To understand whether
this facilitation was dependent on syntaxin, a constant concentration
of Hrs-2 was incubated with GST-SNAP-25 in the presence of increasing
concentrations of syntaxin (Fig. 4). As the concentration of syntaxin
was increased, we observed more Hrs-2 binding. These data demonstrate
that syntaxin binding to SNAP-25 enhances the ability of Hrs-2 to
associate with SNAP-25.
The effect of Hrs-2 on VAMP binding to SNAP-25 was examined by
incubating increasing concentrations of Hrs-2 in a reaction containing
VAMP and GST-SNAP-25 (Fig. 5). As the concentration of Hrs-2 was
increased, the ability of VAMP to bind to GST-SNAP-25 was diminished in
a concentration-dependent manner. Since Hrs-2 has a lower
EC50 for SNAP-25 than VAMP, even in the presence of syntaxin (Table I), these data suggest
that Hrs-2 may interfere with VAMP assembly into the 7 S core
complex.
We next examined the effect of Hrs-2 on 7 S complex assembly (Fig. 6).
The trimeric reaction involving Hrs-2, SNAP-25, and VAMP demonstrated
that Hrs-2 interferes with the ability of VAMP to bind to SNAP-25. The
quaternary reaction involving Hrs-2 and the three 7 S complex binding
partners (GST-SNAP-25, syntaxin, and VAMP) reveals that when Hrs-2 is
added to the 7 S complex in increasing concentrations, the amount of
VAMP incorporated into the 7 S complex decreases. When the
concentration of Hrs-2 reaches binding saturation, VAMP incorporation
is reduced by 80%.
It is possible that the 7 S complex still forms despite the presence of
Hrs-2, albeit with greatly reduced efficiency. Alternatively, the 7 S
complex may not form at all, and the small amount of VAMP we detect is
only associated with syntaxin. Additional studies will be needed to
clarify the precise structural impact of Hrs-2 on the 7 S complex.
 |
DISCUSSION |
Recent evidence suggests a role for Hrs-2 in the secretory
machinery. Hrs-2 physically interacts in a
Ca2+-dependent manner with SNAP-25, a component
of a core protein complex thought to be essential for neurotransmitter
release. (19). Additionally, both Hrs-2 and SNAP-25 are present in
nerve terminals as demonstrated by light (24) and electron microscopic studies3 as well as
biochemical fractionation
studies.4 Moreover,
recombinant Hrs-2 inhibits secretion in permeabilized PC-12 cells (19).
In the present study, we have identified the protein domains mediating
the interaction between SNAP-25 and Hrs-2. We show that Hrs-2 and
SNAP-25 interact through regions that are predicted to form -helical
coiled-coils on both proteins. We have also examined the effect of
Hrs-2 on other SNAP-25-interacting proteins. The interaction of Hrs-2
with SNAP-25 is enhanced in the presence of syntaxin. Furthermore,
either Hrs-2 or VAMP may bind to SNAP-25; however, they cannot bind
simultaneously. Additionally, increasing amounts of Hrs-2 added to the
7S complex results in a disassociation of VAMP from that complex. These
data suggest that Hrs-2 may be involved in regulating the formation of
the 7 S protein complex through interactions with SNAP-25.
-Helical coiled-coils are a common structural motif through which
protein-protein interactions can occur (26, 27). Hrs-2 contains two
regions predicted to form coiled-coils (19), and we show that SNAP-25
binds to the second coiled-coil of Hrs-2 (Fig. 1). SNAP-25 is predicted
to form three coiled-coils (10). An ordered coiled-coil structure over
the first two coiled-coils of SNAP-25 is induced when syntaxin
interacts with the amino terminus of SNAP-25 (11, 12). In addition, the
carboxyl-terminal region of SNAP-25 also becomes structured, most
likely forming a third coiled-coil (11, 13). Like syntaxin, Hrs-2 may
also transform the structure of SNAP-25 such that the ability of
SNAP-25 to associate with other proteins is altered.
Within the context of the 7 S complex, VAMP interacts with the third
coiled-coil of SNAP-25. Thus, although VAMP and Hrs-2 are not competing
for the same binding site on SNAP-25, the presence of Hrs-2 inhibits
VAMP binding. The inhibition of VAMP binding may result from Hrs-2
binding to SNAP-25. The interaction of Hrs-2 with SNAP-25 may fail to
promote an ordered structure in the third coiled-coil region of SNAP-25
where VAMP binds (12). An alternative possibility is that steric
hindrance due to the binding of Hrs-2 prevents VAMP binding.
Our results show that formation of the SNAP-25·syntaxin complex
enhances the binding of Hrs-2 to SNAP-25. The binding of Hrs-2 to the
syntaxin·SNAP-25 complex may be favored over VAMP binding, since
Hrs-2 has a higher binding EC50 for this complex. The
presence of Hrs-2 effectively blocks VAMP from interacting with
SNAP-25. Moreover, Hrs-2 appears to prevent the formation of the 7 S
complex by competing with VAMP for entry into the complex. It is
possible that the 7 S complex still forms despite the presence of
Hrs-2, albeit with greatly reduced efficiency. Alternatively, under
these conditions the 7 S complex may not form at all, although a small amount of VAMP remains able to associate with the syntaxin that is not
present in the 7 S complex. Additional studies will be needed to
clarify the precise structural impact of Hrs-2 on the 7 S complex.
The present data indicate that Hrs-2 has a regulatory role on the
exocytic machinery and suggest a heuristic model whereby following an
influx of calcium, a conformational change in Hrs-2 may dissociate
Hrs-2 from SNAP-25, allowing VAMP to bind and the 7 S complex to
assemble. This model predicts that Hrs-2 would inhibit secretion when
present prior to formation of the 7 S complex. In permeabilized PC12
cells, Hrs-2 inhibits secretion of 3H-labeled
norepinephrine when added during the Mg-ATP-dependent "priming" step (19). This step precedes
Ca2+-dependent fusion and has been shown to
correlate with an ATP-dependent catalysis of the 20 S
complex that leaves only the SNAP-25/syntaxin interaction intact (28).
The addition of exogenous Hrs-2 at this stage in the assay may compete
for VAMP binding and inhibit 3H-labeled norepinephrine
release. Thus, Hrs-2 appears to act prior to the "priming" step in
the vesicle life cycle, which may correspond to the movement of
vesicles from an endocytic/sorting/recycling phase to a releasable state.
 |
ACKNOWLEDGEMENTS |
We thank Yuchieh Chang and Bill Evans for
contributing to these studies. We also thank Drs. Shu-Chan Hsu, Karen
Ervin, Neal Waxham, and Tom Vida for helpful discussions and Drs.
Waxham and Vida for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by the Mallinckrodt
Foundation and National Institutes of Health Grant MH058920.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Neurobiology
and Anatomy, University of Texas Medical School, 6431 Fannin St., Rm.
7.208, Houston, TX 77030. Tel.: 713-500-5614; Fax: 713-500-0623; E-mail: abean@nba19.med.uth.tmc.edu.
2
S. Tsujimoto and A.J. Bean, unpublished observations.
3
S. Davanger and A.J. Bean, unpublished observations.
4
A. J. Bean, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
SNAP-25, synaptosomal associated protein of 25 kDa;
VAMP, vesicle-associated
membrane protein;
Hrs-2, hepatocyte growth factor-regulated tyrosine
kinase substrate 2;
GST, glutathione S-transferase.
 |
REFERENCES |
| 1.
|
Kuffler, S. W.,
Nicholls, J. G.,
and Martin, A. R.
(1984)
From Neuron to Brain
, 2nd Ed.
, Sinauer, Sunderland, MA
|
| 2.
|
Robinson, L. J.,
and Martin, T. F.
(1998)
Curr. Opin. Cell Biol.
10,
483-492[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hay, J. C.,
and Scheller, R. H.
(1997)
Curr. Opin. Cell Biol.
9,
505-512[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Hanson, P. I.,
Hetser, J. E.,
and Jahn, R.
(1997)
Curr. Opin. Neurobiol.
7,
310-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Sudhof, T. C.
(1995)
Nature
375,
645-653[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Rothman, J. E.
(1994)
Nature
372,
55-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Sollner, T.,
Bennett, M. K.,
Whiteheart, S. W.,
Scheller, R. H.,
and Rothman, J. E.
(1993)
Cell
75,
409-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Sollner, T.,
Whiteheart, S. W.,
Brunner, M.,
Erdjument-Bromage, H.,
Geromanos, S.,
Tempst, P.,
and Rothman, J. E.
(1993)
Nature
362,
318-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Oyler, G. A.,
Higgins, G. A.,
Hart, R. A.,
Battenberg, E.,
Billingsley, M.,
Bloom, F. E.,
and Wilson, M. C.
(1989)
J. Cell Biol.
109,
3039-3052[Abstract/Free Full Text]
|
| 10.
|
Chapman, E. R.,
An, S.,
Barton, N.,
and Jahn, R.
(1994)
J. Biol. Chem.
269,
27427-27432[Abstract/Free Full Text]
|
| 11.
|
Fasshauer, D.,
Bruns, D.,
Shen, B.,
Jahn, R.,
and Brunger, A. T.
(1997)
J. Biol. Chem.
272,
4582-4590[Abstract/Free Full Text]
|
| 12.
|
Fasshauer, D.,
Otto, H.,
Eliason, W. K.,
Jahn, R.,
and Brunger, A. T.
(1997)
J. Biol. Chem.
272,
28036-28041[Abstract/Free Full Text]
|
| 13.
|
Hayashi, T.,
McMahon, H.,
Yamasaki, S.,
Binz, T.,
Hata, Y.,
Sudhof, T. C.,
and Niemann, H.
(1994)
EMBO J.
13,
5051-5061[Medline]
[Order article via Infotrieve]
|
| 14.
|
Pevsner, J.,
Hsu, S.-C.,
Braun, J. E. A.,
Calakos, N.,
Ting, A. E.,
Bennett, M. K.,
and Scheller, R. H.
(1994)
Neuron
13,
353-361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Sutton, R. B.,
Fasshauer, D.,
Jahn, R.,
and Brunger, A. T.
(1998)
Nature
395,
347-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Poirier, M. A.,
Hao, J. C.,
Malkus, P. N.,
Chan, C.,
Moore, M. F.,
King, D. S.,
and Bennett, M. K.
(1998)
J. Biol. Chem.
273,
11370-11377[Abstract/Free Full Text]
|
| 17.
|
Pellegrini, L. L.,
O'Connor, V.,
Lottspeich, F.,
and Betz, H.
(1995)
EMBO J.
14,
4705-4713[Medline]
[Order article via Infotrieve]
|
| 18.
|
Washbourne, P.,
Pellizzari, R.,
Baldini, G.,
Wilson, M. C.,
and Montecucco, C.
(1997)
FEBS Lett.
418,
1-5[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Bean, A. J.,
Seifert, R,
Chen, Y. A.,
Sacks, R.,
and Scheller, R. H.
(1997)
Nature
385,
826-829[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Fasshauer, D.,
Eliason, W. K.,
Brunger, A. T.,
and Jahn, R.
(1998)
Biochemistry
37,
10354-10362[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Weber, T.,
Zemelman, B. V.,
McNew, J. A.,
Westermann, B.,
Gmachl, M.,
Parlati, F.,
Sollner, T. H.,
and Rothman, J. E.
(1998)
Cell
92,
759-772[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Calakos, N.,
Bennett, M. K.,
Peterson, K. E.,
and Scheller, R. H.
(1994)
Science
263,
1146-1149[Abstract/Free Full Text]
|
| 23.
|
Bennett, M. K.,
Calakos, N.,
and Scheller, R. H.
(1992)
Science
257,
255-259[Abstract/Free Full Text]
|
| 24.
|
Tsujimoto, S.,
Pelto-Huikko, M.,
Aitola, M.,
Meister, B.,
Vik-Mo, E. O.,
Davanger, S.,
Scheller, R. H.,
and Bean, A. J.
(1999)
Eur. J. Neurosci
11,
3047-3063[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Hao, J. C.,
Salem, N.,
Peng, X.,
Kelly, R. B.,
and Bennett, M. K.
(1997)
J. Neurosci.
17,
1596-1603[Abstract/Free Full Text]
|
| 26.
|
Kohn, W. D.,
Mant, C. T.,
and Hodges, R. S.
(1997)
J. Biol. Chem.
272,
2583-2586[Free Full Text]
|
| 27.
|
Lupas, A.
(1996)
Trends Biochem. Sci.
21,
375-382[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Banerjee, A.,
Barry, V. A.,
DasGupta, B. R.,
and Martin, T. F. J.
(1996)
J. Biol. Chem.
271,
20223-20226[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q. Yan, W. Sun, P. Kujala, Y. Lotfi, T. A. Vida, and A. J. Bean
CART: An Hrs/Actinin-4/BERP/Myosin V Protein Complex Required for Efficient Receptor Recycling
Mol. Biol. Cell,
May 1, 2005;
16(5):
2470 - 2482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yan, W. Sun, J. A. McNew, T. A. Vida, and A. J. Bean
Ca2+ and N-Ethylmaleimide-sensitive Factor Differentially Regulate Disassembly of SNARE Complexes on Early Endosomes
J. Biol. Chem.,
April 30, 2004;
279(18):
18270 - 18276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Sun, Q. Yan, T. A. Vida, and A. J. Bean
Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex
J. Cell Biol.,
July 7, 2003;
162(1):
125 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Lu, L. W. Hope, M. Brasch, C. Reinhard, and S. N. Cohen
TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation
PNAS,
June 24, 2003;
100(13):
7626 - 7631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shukla, H. Hager, T. J. Corydon, A. J. Bean, R. Dahl, Z. Vajda, H. Li, H. J. Hoffmann, and S. Nielsen
SNAP-25-associated Hrs-2 protein colocalizes with AQP2 in rat kidney collecting duct principal cells
Am J Physiol Renal Physiol,
September 1, 2001;
281(3):
F546 - F556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Urbé, I. G. Mills, H. Stenmark, N. Kitamura, and M. J. Clague
Endosomal Localization and Receptor Dynamics Determine Tyrosine Phosphorylation of Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate
Mol. Cell. Biol.,
October 15, 2000;
20(20):
7685 - 7692.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Bean, S. Davanger, M. F. Chou, B. Gerhardt, S. Tsujimoto, and Y. Chang
Hrs-2 Regulates Receptor-mediated Endocytosis via Interactions with Eps15
J. Biol. Chem.,
May 12, 2000;
275(20):
15271 - 15278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Kwong, F. Roundabush, P Hutton Moore, M Montague, W Oldham, Y Li, L. Chin, and L Li
Hrs interacts with SNAP-25 and regulates Ca(2+)-dependent exocytosis
J. Cell Sci.,
January 6, 2000;
113(12):
2273 - 2284.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, L.-S. Chin, C. Weigel, and L. Li
Spring, a Novel RING Finger Protein That Regulates Synaptic Vesicle Exocytosis
J. Biol. Chem.,
October 26, 2001;
276(44):
40824 - 40833.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|